110 related articles for article (PubMed ID: 433375)
1. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
Leuschner U; Schneider M; Korte L
Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
[TBL] [Abstract][Full Text] [Related]
2. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
[TBL] [Abstract][Full Text] [Related]
3. Chenodeoxycholic acid (CDCA) versus ursodeoxycholic acid (UDCA): a comparison of their effects in pregnant rats.
Celle G; Cavanna M; Bocchini R; Robbiano L; Dodero M; Volpi C; Dellepiane F; Cuneo-Crovari P; Scarvaglieri-Giuliano R; Sigari-Canu G
Arch Int Pharmacodyn Ther; 1980 Jul; 246(1):149-58. PubMed ID: 7447544
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
5. Further observations on the in vitro metabolism of chenodeoxycholic acid and ursodeoxycholic acid.
Albini E; Marca G; Mellerio G
Arzneimittelforschung; 1982; 32(12):1554-7. PubMed ID: 6891595
[TBL] [Abstract][Full Text] [Related]
6. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
7. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
8. [Morphologic, animal experimental study on the question of sex specific liver lesions due to chenodesoxycholic acid].
Leuschner U; JOCK C
Z Gastroenterol; 1977 Jan; 15(1):29-36. PubMed ID: 835312
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
Xiao ZL; Biancani P; Carey MC; Behar J
Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
[TBL] [Abstract][Full Text] [Related]
10. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
12. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
von Bergmann K; Epple-Gutsfeld M; Leiss O
Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
[TBL] [Abstract][Full Text] [Related]
13. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
Einarsson C; Hillebrant CG; Axelson M
Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of chenodeoxycholic acid in the rhesus monkey.
Dyrszka H; Chen T; Salen G; Mosbach EH
Gastroenterology; 1975 Aug; 69(2):333-7. PubMed ID: 1150041
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
Fromm H
J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
[TBL] [Abstract][Full Text] [Related]
18. [Effects of chenodeoxycholic acid (CDCA) and ursodeoxycholic (UDCA) to glucose transport in hamster small intestine in vitro--a study on the mechanism of diarrhea due to CDCA therapy (author's transl)].
Nakamura T; Ohkuni A; Yamanaka M
Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1355-61. PubMed ID: 7441911
[No Abstract] [Full Text] [Related]
19. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects.
Leuschner U; Guldutuna S; Bhatti S; Elze A; Imhof M; You T; Zimmer G
Ital J Gastroenterol; 1995 Sep; 27(7):376-7. PubMed ID: 8563010
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Narisawa T; Fukaura Y; Terada K; Sekiguchi H
J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
